rs121908701
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
|
|
|
rs121908702
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
|
|
|
rs137853009
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
|
|
|
rs137853010
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
|
|
|
rs141568342
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
|
|
|
rs143611747
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
|
|
|
rs540635787
|
|
A |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs587780189
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
|
|
|
rs587780194
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
Early detection of prostate cancer: AUA Guideline.
|
23659877 |
2013 |
rs587780194
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment.
|
25394175 |
2015 |
rs587780194
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology.
|
22138009 |
2011 |
rs587780194
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.
|
19042984 |
2008 |
rs587780194
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
Recommendations from the EGAPP Working Group: does PCA3 testing for the diagnosis and management of prostate cancer improve patient health outcomes?
|
24071797 |
2014 |
rs587781667
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
|
|
|
rs587782401
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs72552322
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
|
|
|
rs750984976
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
Recommendations from the EGAPP Working Group: does PCA3 testing for the diagnosis and management of prostate cancer improve patient health outcomes?
|
24071797 |
2014 |
rs750984976
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
Early detection of prostate cancer: AUA Guideline.
|
23659877 |
2013 |
rs750984976
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment.
|
25394175 |
2015 |
rs750984976
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.
|
19042984 |
2008 |
rs750984976
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology.
|
22138009 |
2011 |
rs77130927
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
Early detection of prostate cancer: AUA Guideline.
|
23659877 |
2013 |
rs77130927
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology.
|
22138009 |
2011 |
rs77130927
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.
|
19042984 |
2008 |
rs77130927
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment.
|
25394175 |
2015 |